1-11 of 11 results for subject:Patients
Librarians' tools
- Search time
- 0.165 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:Patients
- We searched for
- subject_t:Patients OR subject_t:"Sick people" OR subject_ses:92375
Type
House
Session
Year
Department
Member
More
Masham of Ilton, Baroness (11)
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Prices (11)
Publisher
My Lords, I thank the noble Lord, Lord Field of Birkenhead, who moved this amendment so movingly. This debate has gone on for many years.
It has been found by parents that medical cannabis can help some children who have multiple seizures due to epilepsy. I need to know: has NICE...
My Lords, I thank the noble Lord, Lord Field of Birkenhead, who moved this amendment so movingly. This debate has gone on for many years.
It has been found by parents that medical cannabis can help some children who have multiple seizures due to epilepsy. I need to know: has NICE...
Member
Baroness Masham of Ilton
(Crossbench)
Type
Proceeding contributions
Procedure
Virtual contributions
Legislation
Patents Act 1977; Medicines and Medical Devices Bill 2019-21; Human Tissue (Quality and Safety for Human Application) Regulations 2007
Subjects
Complaints; Disclosure of information; Codes of practice; Consent to medical treatment; Cannabis; Consolidation bills; Developing countries; Delegated legislation; Counterfeit manufacturing; China; Health services; Licensing; Human rights; Environment protection; Drugs; Export controls; Intellectual property; Import controls; Law Commission; Epilepsy; Medical treatments; Patients; Ministerial powers; Northern Ireland; Manufacturing industries; Public appointments; Public bodies; Prescription drugs; Public consultation; Patents; Parliamentary scrutiny; Packaging; Minority groups; Prices; Medical equipment; Standards; Regulation; Transplant surgery; Safety; Research; Waste; Vaccination; Veterinary services; Henry VIII clauses; TRIPS Agreement; Human Tissue Authority; Medicines and Healthcare products Regulatory Agency; World Health Organization; Clinical trials; Public health; Medicines and Medical Devices Safety Independent Review; Antimicrobials; Coronavirus; Sunset clauses; Human tissue
Date
12 January 2021
Reference
809 c718
Chamber / Committee
House of Lords chamber
House
House of Lords
My Lords, I agree with the noble Lord, Lord Lansley. It is very good news that there is to be a patient safety commissioner. I congratulate everyone who has worked so hard to create this amendment, especially the noble Baroness, Lady Cumberlege. It is so good that the Government have...
My Lords, I agree with the noble Lord, Lord Lansley. It is very good news that there is to be a patient safety commissioner. I congratulate everyone who has worked so hard to create this amendment, especially the noble Baroness, Lady Cumberlege. It is so good that the Government have...
Member
Baroness Masham of Ilton
(Crossbench)
Type
Proceeding contributions
Procedure
Virtual contributions
Legislation
Patents Act 1977; Medicines and Medical Devices Bill 2019-21; Human Tissue (Quality and Safety for Human Application) Regulations 2007
Subjects
Complaints; Disclosure of information; Codes of practice; Consent to medical treatment; Cannabis; Consolidation bills; Developing countries; Delegated legislation; Counterfeit manufacturing; China; Health services; Licensing; Human rights; Environment protection; Drugs; Export controls; Intellectual property; Import controls; Law Commission; Epilepsy; Medical treatments; Patients; Ministerial powers; Northern Ireland; Manufacturing industries; Public appointments; Public bodies; Prescription drugs; Public consultation; Patents; Parliamentary scrutiny; Packaging; Minority groups; Prices; Medical equipment; Standards; Regulation; Transplant surgery; Safety; Research; Waste; Vaccination; Veterinary services; Henry VIII clauses; TRIPS Agreement; Human Tissue Authority; Medicines and Healthcare products Regulatory Agency; World Health Organization; Clinical trials; Public health; Medicines and Medical Devices Safety Independent Review; Antimicrobials; Coronavirus; Sunset clauses; Human tissue
Date
12 January 2021
Reference
809 cc626-7
Chamber / Committee
House of Lords chamber
House
House of Lords
My Lords, I support these amendments. It seems totally sensible to consolidate legislation so that it is not fragmented and some medicines do not get missed. Medicines and medical devices are vital to some people. We depend on many of our medicines and devices coming from abroad, so bringing legislation...
My Lords, I support these amendments. It seems totally sensible to consolidate legislation so that it is not fragmented and some medicines do not get missed. Medicines and medical devices are vital to some people. We depend on many of our medicines and devices coming from abroad, so bringing legislation...
Member
Baroness Masham of Ilton
(Crossbench)
Type
Proceeding contributions
Procedure
Virtual contributions
Legislation
Patents Act 1977; Medicines and Medical Devices Bill 2019-21; Human Tissue (Quality and Safety for Human Application) Regulations 2007
Subjects
Complaints; Disclosure of information; Codes of practice; Consent to medical treatment; Cannabis; Consolidation bills; Developing countries; Delegated legislation; Counterfeit manufacturing; China; Health services; Licensing; Human rights; Environment protection; Drugs; Export controls; Intellectual property; Import controls; Law Commission; Epilepsy; Medical treatments; Patients; Ministerial powers; Northern Ireland; Manufacturing industries; Public appointments; Public bodies; Prescription drugs; Public consultation; Patents; Parliamentary scrutiny; Packaging; Minority groups; Prices; Medical equipment; Standards; Regulation; Transplant surgery; Safety; Research; Waste; Vaccination; Veterinary services; Henry VIII clauses; TRIPS Agreement; Human Tissue Authority; Medicines and Healthcare products Regulatory Agency; World Health Organization; Clinical trials; Public health; Medicines and Medical Devices Safety Independent Review; Antimicrobials; Coronavirus; Sunset clauses; Human tissue
Date
12 January 2021
Reference
809 c639
Chamber / Committee
House of Lords chamber
House
House of Lords
My Lords, I thank the noble Baroness, Lady Bennett of Manor Castle, for tabling this very important amendment. For a long time, I have been interested in the growing resistance to antibiotics. The residue of many of them, used for both humans and animals, pass into the environment by different...
My Lords, I thank the noble Baroness, Lady Bennett of Manor Castle, for tabling this very important amendment. For a long time, I have been interested in the growing resistance to antibiotics. The residue of many of them, used for both humans and animals, pass into the environment by different...
Member
Baroness Masham of Ilton
(Crossbench)
Type
Proceeding contributions
Procedure
Virtual contributions
Legislation
Patents Act 1977; Medicines and Medical Devices Bill 2019-21; Human Tissue (Quality and Safety for Human Application) Regulations 2007
Subjects
Complaints; Disclosure of information; Codes of practice; Consent to medical treatment; Cannabis; Consolidation bills; Developing countries; Delegated legislation; Counterfeit manufacturing; China; Health services; Licensing; Human rights; Environment protection; Drugs; Export controls; Intellectual property; Import controls; Law Commission; Epilepsy; Medical treatments; Patients; Ministerial powers; Northern Ireland; Manufacturing industries; Public appointments; Public bodies; Prescription drugs; Public consultation; Patents; Parliamentary scrutiny; Packaging; Minority groups; Prices; Medical equipment; Standards; Regulation; Transplant surgery; Safety; Research; Waste; Vaccination; Veterinary services; Henry VIII clauses; TRIPS Agreement; Human Tissue Authority; Medicines and Healthcare products Regulatory Agency; World Health Organization; Clinical trials; Public health; Medicines and Medical Devices Safety Independent Review; Antimicrobials; Coronavirus; Sunset clauses; Human tissue
Date
12 January 2021
Reference
809 c679
Chamber / Committee
House of Lords chamber
House
House of Lords
My Lords, does the Minister think that the Statement will make postcode prescribing better or worse? Surely that is the real problem of a two-tier system.
My Lords, does the Minister think that the Statement will make postcode prescribing better or worse? Surely that is the real problem of a two-tier system.
Member
Baroness Masham of Ilton
(Crossbench)
Type
Proceeding contributions
Subjects
Access; Cancer; Finance; Fees and charges; Drugs; Private sector; NHS; Medical treatments; Patients; Prices; Palliative care; National Institute for Health and Care Excellence; Consequences of Additional Private Drugs for NHS Care Review
Date
4 November 2008
Reference
705 c156
Chamber / Committee
House of Lords chamber
House
House of Lords
asked Her Majesty's Government:Whether the healthcare professionals who advised the Department of Health on reclassification of Part IX of the Drug Tariff were informed that this classification would be used as the basis of a proposed pricing system; and
asked Her Majesty's Government:Whether the healthcare professionals who advised the Department of Health on reclassification of Part IX of the Drug Tariff were informed that this classification would be used as the basis of a proposed pricing system; and
Asked by
Baroness Masham of Ilton
(Crossbench)
Answered by
Lord Darzi of Denham
(Labour)
Type
Written questions
Status
Answered
Answered on
5 February 2008
The healthcare professionals who advised the department on the classification were asked to focus on whether or not products could meet similar medical need. They were not asked to consider price.
The panel will be reconvened but it will be extended to include representatives from industry and patients.
Over 5,000 items are listed in Part IX of the Drug Tariff. In relation to the proposed classification that was published in September 2007, 478 editorial changes have been requested; the majority could be considered errors, for example incorrect reference codes. In addition, 124 omissions have been identified mainly as a result of companies’ change of ownership during the course of this consultation. These will be corrected when the classification is revisited.
The role of National Health Service specialist nurses is outside the scope of this review and we do not anticipate that their workload will be affected. However, officials have met with representatives from the NHS, for example representatives from the Royal College of Nurses and the World Council of Enterostomal Therapists. They have also met with a nurse who specialises in childhood incontinence, as such patients have very special needs.
Under their terms of service, dispensing appliance contractors are not required to do anything but dispense an appliance. However, many of them employ nurses of their own; these nurses make home visits to patients at the discretion of the contractor. While we recognise the contribution these individuals make to patient care, we believe that their role is to complement the work of NHS specialist nurses. As such, we need to ensure that they are suitably qualified to deal directly with patients.
Given this, in the proposed amendments to dispensing appliance contractors' and pharmacists' terms of service it states: "““‘Specialist nurse’ means a person registered in the Nurses' Part or Specialist Community Public Health Nurses' Part of the professional register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001””."
Compliance with this proposed amendment would be the responsibility of the employer, ie the dispensing appliance contractor or the pharmacist.
As noted, the role of specialist nurses employed by the NHS is not in scope. There are no restrictions on their ability to provide follow-up visits to users of stoma and incontinence appliances. As such, we anticipate that levels of infection should not increase. However, given the role of specialist nurses employed directly by providers to complement the work of NHS specialists, we will discuss this with interested parties when we next meet.
Subjects
Infectious diseases; Home care services; NHS; Patients; Pharmacy; Nurses; Prices; Medical equipment; Incontinence
Date
5 February 2008
Reference
1499; 698 c167-9WA
House
House of Lords
Whether the healthcare professionals who advised the Department of Health on reclassification of Part IX of the Drug Tariff will be reconvened to consider correcting the errors, omissions and inaccuracies identified by industry; and
Whether the healthcare professionals who advised the Department of Health on reclassification of Part IX of the Drug Tariff will be reconvened to consider correcting the errors, omissions and inaccuracies identified by industry; and
Asked by
Baroness Masham of Ilton
(Crossbench)
Answered by
Lord Darzi of Denham
(Labour)
Type
Written questions
Status
Answered
Answered on
5 February 2008
The healthcare professionals who advised the department on the classification were asked to focus on whether or not products could meet similar medical need. They were not asked to consider price.
The panel will be reconvened but it will be extended to include representatives from industry and patients.
Over 5,000 items are listed in Part IX of the Drug Tariff. In relation to the proposed classification that was published in September 2007, 478 editorial changes have been requested; the majority could be considered errors, for example incorrect reference codes. In addition, 124 omissions have been identified mainly as a result of companies’ change of ownership during the course of this consultation. These will be corrected when the classification is revisited.
The role of National Health Service specialist nurses is outside the scope of this review and we do not anticipate that their workload will be affected. However, officials have met with representatives from the NHS, for example representatives from the Royal College of Nurses and the World Council of Enterostomal Therapists. They have also met with a nurse who specialises in childhood incontinence, as such patients have very special needs.
Under their terms of service, dispensing appliance contractors are not required to do anything but dispense an appliance. However, many of them employ nurses of their own; these nurses make home visits to patients at the discretion of the contractor. While we recognise the contribution these individuals make to patient care, we believe that their role is to complement the work of NHS specialist nurses. As such, we need to ensure that they are suitably qualified to deal directly with patients.
Given this, in the proposed amendments to dispensing appliance contractors' and pharmacists' terms of service it states: "““‘Specialist nurse’ means a person registered in the Nurses' Part or Specialist Community Public Health Nurses' Part of the professional register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001””."
Compliance with this proposed amendment would be the responsibility of the employer, ie the dispensing appliance contractor or the pharmacist.
As noted, the role of specialist nurses employed by the NHS is not in scope. There are no restrictions on their ability to provide follow-up visits to users of stoma and incontinence appliances. As such, we anticipate that levels of infection should not increase. However, given the role of specialist nurses employed directly by providers to complement the work of NHS specialists, we will discuss this with interested parties when we next meet.
Subjects
Infectious diseases; Home care services; NHS; Patients; Pharmacy; Nurses; Prices; Medical equipment; Incontinence
Date
5 February 2008
Reference
1500; 698 c167-9WA
House
House of Lords
How many errors, inaccuracies and omissions were identified by industry within the Department of Health's new Part IX Drug Tariff categories; and
How many errors, inaccuracies and omissions were identified by industry within the Department of Health's new Part IX Drug Tariff categories; and
Asked by
Baroness Masham of Ilton
(Crossbench)
Answered by
Lord Darzi of Denham
(Labour)
Type
Written questions
Status
Answered
Answered on
5 February 2008
The healthcare professionals who advised the department on the classification were asked to focus on whether or not products could meet similar medical need. They were not asked to consider price.
The panel will be reconvened but it will be extended to include representatives from industry and patients.
Over 5,000 items are listed in Part IX of the Drug Tariff. In relation to the proposed classification that was published in September 2007, 478 editorial changes have been requested; the majority could be considered errors, for example incorrect reference codes. In addition, 124 omissions have been identified mainly as a result of companies’ change of ownership during the course of this consultation. These will be corrected when the classification is revisited.
The role of National Health Service specialist nurses is outside the scope of this review and we do not anticipate that their workload will be affected. However, officials have met with representatives from the NHS, for example representatives from the Royal College of Nurses and the World Council of Enterostomal Therapists. They have also met with a nurse who specialises in childhood incontinence, as such patients have very special needs.
Under their terms of service, dispensing appliance contractors are not required to do anything but dispense an appliance. However, many of them employ nurses of their own; these nurses make home visits to patients at the discretion of the contractor. While we recognise the contribution these individuals make to patient care, we believe that their role is to complement the work of NHS specialist nurses. As such, we need to ensure that they are suitably qualified to deal directly with patients.
Given this, in the proposed amendments to dispensing appliance contractors' and pharmacists' terms of service it states: "““‘Specialist nurse’ means a person registered in the Nurses' Part or Specialist Community Public Health Nurses' Part of the professional register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001””."
Compliance with this proposed amendment would be the responsibility of the employer, ie the dispensing appliance contractor or the pharmacist.
As noted, the role of specialist nurses employed by the NHS is not in scope. There are no restrictions on their ability to provide follow-up visits to users of stoma and incontinence appliances. As such, we anticipate that levels of infection should not increase. However, given the role of specialist nurses employed directly by providers to complement the work of NHS specialists, we will discuss this with interested parties when we next meet.
Subjects
Infectious diseases; Home care services; NHS; Patients; Pharmacy; Nurses; Prices; Medical equipment; Incontinence
Date
5 February 2008
Reference
1501; 698 c167-9WA
House
House of Lords
What discussions they have had with (a) the British Association of Urology Nurses; (b) the Royal College of Nursing; and (c) the Association for Continence Advice, to assess the impact on the workload of specialist nurses if the Department of Health's proposals relating to Part IX of the Drug Tariff...
What discussions they have had with (a) the British Association of Urology Nurses; (b) the Royal College of Nursing; and (c) the Association for Continence Advice, to assess the impact on the workload of specialist nurses if the Department of Health's proposals relating to Part IX of the Drug Tariff...
Asked by
Baroness Masham of Ilton
(Crossbench)
Answered by
Lord Darzi of Denham
(Labour)
Type
Written questions
Status
Answered
Answered on
5 February 2008
The healthcare professionals who advised the department on the classification were asked to focus on whether or not products could meet similar medical need. They were not asked to consider price.
The panel will be reconvened but it will be extended to include representatives from industry and patients.
Over 5,000 items are listed in Part IX of the Drug Tariff. In relation to the proposed classification that was published in September 2007, 478 editorial changes have been requested; the majority could be considered errors, for example incorrect reference codes. In addition, 124 omissions have been identified mainly as a result of companies’ change of ownership during the course of this consultation. These will be corrected when the classification is revisited.
The role of National Health Service specialist nurses is outside the scope of this review and we do not anticipate that their workload will be affected. However, officials have met with representatives from the NHS, for example representatives from the Royal College of Nurses and the World Council of Enterostomal Therapists. They have also met with a nurse who specialises in childhood incontinence, as such patients have very special needs.
Under their terms of service, dispensing appliance contractors are not required to do anything but dispense an appliance. However, many of them employ nurses of their own; these nurses make home visits to patients at the discretion of the contractor. While we recognise the contribution these individuals make to patient care, we believe that their role is to complement the work of NHS specialist nurses. As such, we need to ensure that they are suitably qualified to deal directly with patients.
Given this, in the proposed amendments to dispensing appliance contractors' and pharmacists' terms of service it states: "““‘Specialist nurse’ means a person registered in the Nurses' Part or Specialist Community Public Health Nurses' Part of the professional register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001””."
Compliance with this proposed amendment would be the responsibility of the employer, ie the dispensing appliance contractor or the pharmacist.
As noted, the role of specialist nurses employed by the NHS is not in scope. There are no restrictions on their ability to provide follow-up visits to users of stoma and incontinence appliances. As such, we anticipate that levels of infection should not increase. However, given the role of specialist nurses employed directly by providers to complement the work of NHS specialists, we will discuss this with interested parties when we next meet.
Subjects
Infectious diseases; Home care services; NHS; Patients; Pharmacy; Nurses; Prices; Medical equipment; Incontinence
Date
5 February 2008
Reference
1502; 698 c167-9WA
House
House of Lords
What assessment they have made of the risk of increased patient infections if visits from specialist nurses are capped, as proposed in the Department of Health's consultation on Part IX of the Drug Tariff.
What assessment they have made of the risk of increased patient infections if visits from specialist nurses are capped, as proposed in the Department of Health's consultation on Part IX of the Drug Tariff.
Asked by
Baroness Masham of Ilton
(Crossbench)
Answered by
Lord Darzi of Denham
(Labour)
Type
Written questions
Status
Answered
Answered on
5 February 2008
The healthcare professionals who advised the department on the classification were asked to focus on whether or not products could meet similar medical need. They were not asked to consider price.
The panel will be reconvened but it will be extended to include representatives from industry and patients.
Over 5,000 items are listed in Part IX of the Drug Tariff. In relation to the proposed classification that was published in September 2007, 478 editorial changes have been requested; the majority could be considered errors, for example incorrect reference codes. In addition, 124 omissions have been identified mainly as a result of companies’ change of ownership during the course of this consultation. These will be corrected when the classification is revisited.
The role of National Health Service specialist nurses is outside the scope of this review and we do not anticipate that their workload will be affected. However, officials have met with representatives from the NHS, for example representatives from the Royal College of Nurses and the World Council of Enterostomal Therapists. They have also met with a nurse who specialises in childhood incontinence, as such patients have very special needs.
Under their terms of service, dispensing appliance contractors are not required to do anything but dispense an appliance. However, many of them employ nurses of their own; these nurses make home visits to patients at the discretion of the contractor. While we recognise the contribution these individuals make to patient care, we believe that their role is to complement the work of NHS specialist nurses. As such, we need to ensure that they are suitably qualified to deal directly with patients.
Given this, in the proposed amendments to dispensing appliance contractors' and pharmacists' terms of service it states: "““‘Specialist nurse’ means a person registered in the Nurses' Part or Specialist Community Public Health Nurses' Part of the professional register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001””."
Compliance with this proposed amendment would be the responsibility of the employer, ie the dispensing appliance contractor or the pharmacist.
As noted, the role of specialist nurses employed by the NHS is not in scope. There are no restrictions on their ability to provide follow-up visits to users of stoma and incontinence appliances. As such, we anticipate that levels of infection should not increase. However, given the role of specialist nurses employed directly by providers to complement the work of NHS specialists, we will discuss this with interested parties when we next meet.
Subjects
Infectious diseases; Home care services; NHS; Patients; Pharmacy; Nurses; Prices; Medical equipment; Incontinence
Date
5 February 2008
Reference
1504; 698 c167-9WA
House
House of Lords
What assessment they have made of the impact on specialist nurses' ability to comply with (a) the Nursing and Midwifery Council's Code of Professional Conduct; (b) national occupational standards outlined in Skills for Health; and (c) Medicines and Healthcare Products Regulatory Agency standards on the use of medical devices should...
What assessment they have made of the impact on specialist nurses' ability to comply with (a) the Nursing and Midwifery Council's Code of Professional Conduct; (b) national occupational standards outlined in Skills for Health; and (c) Medicines and Healthcare Products Regulatory Agency standards on the use of medical devices should...
Asked by
Baroness Masham of Ilton
(Crossbench)
Answered by
Lord Darzi of Denham
(Labour)
Type
Written questions
Status
Answered
Answered on
5 February 2008
The healthcare professionals who advised the department on the classification were asked to focus on whether or not products could meet similar medical need. They were not asked to consider price.
The panel will be reconvened but it will be extended to include representatives from industry and patients.
Over 5,000 items are listed in Part IX of the Drug Tariff. In relation to the proposed classification that was published in September 2007, 478 editorial changes have been requested; the majority could be considered errors, for example incorrect reference codes. In addition, 124 omissions have been identified mainly as a result of companies’ change of ownership during the course of this consultation. These will be corrected when the classification is revisited.
The role of National Health Service specialist nurses is outside the scope of this review and we do not anticipate that their workload will be affected. However, officials have met with representatives from the NHS, for example representatives from the Royal College of Nurses and the World Council of Enterostomal Therapists. They have also met with a nurse who specialises in childhood incontinence, as such patients have very special needs.
Under their terms of service, dispensing appliance contractors are not required to do anything but dispense an appliance. However, many of them employ nurses of their own; these nurses make home visits to patients at the discretion of the contractor. While we recognise the contribution these individuals make to patient care, we believe that their role is to complement the work of NHS specialist nurses. As such, we need to ensure that they are suitably qualified to deal directly with patients.
Given this, in the proposed amendments to dispensing appliance contractors' and pharmacists' terms of service it states: "““‘Specialist nurse’ means a person registered in the Nurses' Part or Specialist Community Public Health Nurses' Part of the professional register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001””."
Compliance with this proposed amendment would be the responsibility of the employer, ie the dispensing appliance contractor or the pharmacist.
As noted, the role of specialist nurses employed by the NHS is not in scope. There are no restrictions on their ability to provide follow-up visits to users of stoma and incontinence appliances. As such, we anticipate that levels of infection should not increase. However, given the role of specialist nurses employed directly by providers to complement the work of NHS specialists, we will discuss this with interested parties when we next meet.
Subjects
Infectious diseases; Home care services; NHS; Patients; Pharmacy; Nurses; Prices; Medical equipment; Incontinence
Date
5 February 2008
Reference
1503; 698 c167-9WA
House
House of Lords